Letter to Editor
BibTex RIS Cite
Year 2021, Volume: 3 Issue: 4, 145 - 146, 29.10.2021
https://doi.org/10.46310/tjim.905105

Abstract

Supporting Institution

yok

Project Number

yok

References

  • WHO COVID-19 Case definition. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV Surveillance_Case_Definition-2020.2
  • COVID-19 Rehberi. Available at: https://covid19.saglik.gov.tr/TR-66301/covid-19-rehberi.html
  • Eldin C, Mélenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. From Q Fever to Coxiella burnetii Infection: a Paradigm Change. Clin Microbiol Rev. 2017;30(1):115-90.
  • Köksal E, Günal Ö, Kılıç SS. Q fever: An occupational disease. Klimik Derg. 2020; 33(2): 195-6.
  • Asan A. KLİMİK 2015 XVII. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi Kitabı. 2015; 87-8.
  • Çelebi B, Baş B, Agüloğlu Bali E, Şimşek Yavuz S. Endokarditli Bir Olgudan Coxiella burnetii’nin Türkiye’de İlk İzolasyonu; Antijen Üretimi ve Faz Değişimi Çalışması. Mikrobiyol Bul. 2019;53(3):274-84. doi: 10.5578/mb.68336
  • Coleman JJ, Manavi K, Marson EJ, Botkai AH, Sapey E. COVID-19: to be or not to be; that is the diagnostic question. Postgrad Med J. 2020;96(1137):392-8. doi: 10.1136/postgradmedj-2020-137979.
  • Vink M, Vink-Niese A. Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID-19 fatigue syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome. Healthcare (Basel). 2020 Dec 11;8(4):552. doi: 10.3390/healthcare8040552.
  • Park HS, Bae PK, Jeong HW, Son BR, Shin KS. Serological evidence of Coxiella burnetii and SARS-CoV-2 co-infection: A case report. Ann Lab Med. 2021;41(5):510-3. doi: 10.3343/alm.2021.41.5.510

Q Fever in the Differential Diagnosis of COVID 19 Infection

Year 2021, Volume: 3 Issue: 4, 145 - 146, 29.10.2021
https://doi.org/10.46310/tjim.905105

Abstract

Coxiella burnetii is an intracellular, Gram-negative bacteria and is the causative agent of Q fever, a zoonosis first described in Australia in 1937. It can cause endemics around the world. People usually get the disease by inhaling the contaminated aerosol produced by infected livestock. Contaminated milk, intradermal inoculation, sexual contact, blood transfusion, and transplacental route may also occur. The infective dose for humans is 1-10 bacteria. It is resistant to environmental conditions and can remain alive in animal wastes such as dust and fertilizer. Acute infection is typically asymptomatic or may manifest as a febrile flu-like illness, pneumonia, hepatitis, and central nervous system (CNS) infection. Q fever outbreaks are often caused by occupational exposure that includes shepherds, animal keepers, veterinarians, slaughterhouses or dairy workers, and laboratory personnel working with C. burnetii. During the course of the disease that cannot be distinguished from other pneumonia clinically; 2-10 fold increase in liver function tests, leukocytosis and thrombocytopenia, erythrocyte sedimentation rate and creatine kinase increase may be observed or laboratory findings may be normal. An immunofluorescent antibody (IFA) test, which is a serological reference method, should be requested from patients suspected for the diagnosis of Q fever.

Project Number

yok

References

  • WHO COVID-19 Case definition. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV Surveillance_Case_Definition-2020.2
  • COVID-19 Rehberi. Available at: https://covid19.saglik.gov.tr/TR-66301/covid-19-rehberi.html
  • Eldin C, Mélenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. From Q Fever to Coxiella burnetii Infection: a Paradigm Change. Clin Microbiol Rev. 2017;30(1):115-90.
  • Köksal E, Günal Ö, Kılıç SS. Q fever: An occupational disease. Klimik Derg. 2020; 33(2): 195-6.
  • Asan A. KLİMİK 2015 XVII. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi Kitabı. 2015; 87-8.
  • Çelebi B, Baş B, Agüloğlu Bali E, Şimşek Yavuz S. Endokarditli Bir Olgudan Coxiella burnetii’nin Türkiye’de İlk İzolasyonu; Antijen Üretimi ve Faz Değişimi Çalışması. Mikrobiyol Bul. 2019;53(3):274-84. doi: 10.5578/mb.68336
  • Coleman JJ, Manavi K, Marson EJ, Botkai AH, Sapey E. COVID-19: to be or not to be; that is the diagnostic question. Postgrad Med J. 2020;96(1137):392-8. doi: 10.1136/postgradmedj-2020-137979.
  • Vink M, Vink-Niese A. Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID-19 fatigue syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome. Healthcare (Basel). 2020 Dec 11;8(4):552. doi: 10.3390/healthcare8040552.
  • Park HS, Bae PK, Jeong HW, Son BR, Shin KS. Serological evidence of Coxiella burnetii and SARS-CoV-2 co-infection: A case report. Ann Lab Med. 2021;41(5):510-3. doi: 10.3343/alm.2021.41.5.510
There are 9 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section Letters to the Editor
Authors

Sevil Alkan 0000-0003-1944-2477

Alper Şener 0000-0003-2774-8601

Safiye Bilge Güçlü Kayta 0000-0002-8403-8430

Anıl Akça 0000-0001-5029-9838

Project Number yok
Publication Date October 29, 2021
Submission Date March 30, 2021
Acceptance Date June 30, 2021
Published in Issue Year 2021 Volume: 3 Issue: 4

Cite

EndNote Alkan S, Şener A, Güçlü Kayta SB, Akça A (October 1, 2021) Q Fever in the Differential Diagnosis of COVID 19 Infection. Turkish Journal of Internal Medicine 3 4 145–146.

e-ISSN: 2687-4245 

Turkish Journal of Internal Medicine, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png
2024 -TJIM.org